XIROMED FDA Approval ANDA 090793

ANDA 090793

XIROMED

FDA Drug Application

Application #090793

Application Sponsors

ANDA 090793XIROMED

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-280.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG0TRI-ESTARYLLAETHINYL ESTRADIOL; NORGESTIMATE

FDA Submissions

ORIG1AP2013-01-30
LABELING; LabelingSUPPL3AP2015-08-25STANDARD
LABELING; LabelingSUPPL4AP2015-08-25STANDARD
LABELING; LabelingSUPPL6AP2022-02-03STANDARD
LABELING; LabelingSUPPL10AP2022-04-29STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL4Null15
SUPPL6Null15
SUPPL10Null15

TE Codes

001PrescriptionAB

CDER Filings

XIROMED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90793
            [companyName] => XIROMED
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRI-ESTARYLLA","activeIngredients":"ETHINYL ESTRADIOL; NORGESTIMATE","strength":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TRI-ESTARYLLA","submission":"ETHINYL ESTRADIOL; NORGESTIMATE","actionType":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.